Jan 31 (Reuters) - Trillium Therapeutics Inc TR.TO :
* Trillium Therapeutics doses first patient with TTI-621 in phase 1 solid tumor trial Source text for Eikon: ID:nCCN2Kxdhj Further company coverage: TR.TO
Jan 31 (Reuters) - Trillium Therapeutics Inc TR.TO :
* Trillium Therapeutics doses first patient with TTI-621 in phase 1 solid tumor trial Source text for Eikon: ID:nCCN2Kxdhj Further company coverage: TR.TO